Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objectives: To evaluate the combined predictive value of lung compliance and dynamic oxygenation parameters for high-flow nasal cannula (HFNC) outcomes.

Methods: In this single-center retrospective cohort study, 154 patients with acute respiratory distress syndrome (ARDS) treated with HFNC (flow ≥50 L/min, fraction of inspired oxygen [FiO] ≥0.5) between 2019 and 2022 were analyzed. Data collected included baseline characteristics, lung compliance (measured via mechanical ventilation or computed tomography [CT]), blood gas parameters-partial pressure of arterial oxygen to FiO ratio (PaO/FiO) and its 24-hour change (ΔPaO/FiO) and clinical outcomes. Multivariate logistic regression and receiver operating characteristic (ROC) curve analyses were performed to identify predictors. A nomogram was constructed based on the regression model and validated using ROC curves and calibration plots.

Results: Low baseline lung compliance (<30 mL/cmHO) was independently associated with HFNC failure (odds ratio [OR] =3.52, 95% confidence interval [CI]: 1.92-6.45, P<0.001), as was ΔPaO/FiO<20% at 24 hours (OR=2.84, 95% CI: 1.48-5.43, P=0.002). The combined model yielded superior predictive performance (area under the curve [AUC] =0.88) compared to lung compliance (AUC=0.82) or ΔPaO/FiO alone (AUC=0.73). The nomogram demonstrated good calibration (Hosmer-Lemeshow test, P=0.41) and potential clinical utility. Patients with HFNC failure had longer ICU stays (median 14 vs. 7 days, P<0.001) and higher complication rates, including ventilator-associated pneumonia (34.8% vs. 8.3%, P<0.001) and barotrauma (10.9% vs. 1.9%, P=0.032).

Conclusions: The combination of lung compliance and ΔPaO/FiO improves early identification of HFNC failure and mortality risk, facilitating timely escalation to invasive ventilation. Prospective multicenter studies are needed to validate these findings.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12261171PMC
http://dx.doi.org/10.62347/ELGT2750DOI Listing

Publication Analysis

Top Keywords

lung compliance
16
high-flow nasal
8
nasal cannula
8
acute respiratory
8
respiratory distress
8
distress syndrome
8
retrospective cohort
8
cohort study
8
combined lung
4
compliance
4

Similar Publications

Imaging mass cytometry dataset of small-cell lung cancer tumors and tumor microenvironments.

BMC Res Notes

September 2025

Center for Molecular Medicine Cologne, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany.

Objectives: Small cell lung cancer (SCLC) accounts for approximately 15% of lung tumors and is marked by aggressive growth and early metastatic spread. In this study, we used two SCLC mouse models with differing tumor mutation burdens (TMB). To investigate tumor composition, spatial architecture, and interactions with the surrounding microenvironment, we acquired multiplexed images of mouse lung tumors using imaging mass cytometry (IMC).

View Article and Find Full Text PDF

Background: Enteroviruses, including Coxsackie B (CVB) viruses, can cause severe diseases such as myocarditis, pancreatitis, and meningitis. Vaccines can prevent these complications, but conserved non-neutralizing epitopes in the viral capsid may limit their effectiveness. The immunodominant PALXAXETG motif, located in the VP1 N-terminus, is a highly conserved region in enteroviruses that elicits non-neutralizing antibody responses.

View Article and Find Full Text PDF

Objectives: In non-small cell lung cancer (NSCLC), non-invasive alternatives to biopsy-dependent driver mutation analysis are needed. We reviewed the effectiveness of radiomics alone or with clinical data and assessed the performance of artificial intelligence (AI) models in predicting oncogene mutation status.

Materials And Methods: A PRISMA-compliant literature review for studies predicting oncogene mutation status in NSCLC patients using radiomics was conducted by a multidisciplinary team.

View Article and Find Full Text PDF

Introduction  Chronic Obstructive Pulmonary Disease (COPD) is increasingly recognized not only as a pulmonary condition but as a systemic disorder with significant cardiovascular implications. Acute exacerbations of COPD (AECOPD) further elevate this risk, potentially through a heightened prothrombotic state. This study aimed to evaluate and compare the levels of select prothrombotic biomarkers - fibrinogen, C-reactive protein (CRP), D-dimer, von Willebrand Factor (vWF), homocysteine, lactate dehydrogenase (LDH), and platelet-to-lymphocyte ratio (PLR) - in patients with stable COPD and AECOPD, and to assess their diagnostic and prognostic significance.

View Article and Find Full Text PDF

Hydralazine is an antihypertensive that can induce immune-related adverse effects, such as hydralazine-induced lupus and hydralazine-induced antineutrophilic cytoplasmic antibody (ANCA)-associated vasculitis (AAV). AAV involves necrotizing inflammation of small blood vessels, manifesting as fever, malaise, arthralgia, and myalgia, potentially leading to organ failure. Diagnosis includes clinical evaluation, serological testing for ANCA, and histopathological examination, confirmed by necrotizing granulomatous inflammation in affected tissues.

View Article and Find Full Text PDF